等待开盘 04-01 09:30:00 美东时间
+0.670
+1.43%
华盛资讯3月17日讯,Cactus, Inc. Class A公布2025财年年度业绩,公司年度营收10.79亿美元,同比下降4.5%,归母净利润2.02亿美元,同比下滑13.3%。
03-17 07:17
今日重点评级关注:HC Wainwright & Co.:维持NRX Pharmaceuticals"买入"评级,目标价从40美元升至45美元;RBC Capital:维持NUVATION BIO"跑赢大市"评级,目标价从12美元升至13美元
03-04 10:22
Citigroup analyst Scott Gruber maintains Cactus (NYSE:WHD) with a Buy and raises the price target from $55 to $63.
03-04 02:19
今日重点评级关注:HC Wainwright & Co.:维持Helus Pharma"买入"评级,目标价从55美元升至95美元;HC Wainwright & Co.:维持Compass Pathways"买入"评级,目标价从40美元升至70美元
03-03 20:22
华盛资讯2月27日讯,Cactus, Inc. Class A公布2025财年年度业绩,公司年度营收10.79亿美元,同比下降4.5%,归母净利润1.66亿美元,同比下滑10.5%。
02-27 09:52
Cactus shares are trading lower. The company reported Q4 financial results.
02-27 00:23
Cactus (NYSE:WHD) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.58 by 12.65 percent. This is a 8.45 percent decrease over earnings of $0.71 per share from the same period
02-26 07:01
Companies Reporting Before The Bell • Clear Secure (NYSE:YOU) is expected to re...
02-25 19:11
今日重点评级关注:花旗:维持Telix Pharmaceuticals"买入"评级,目标价从22美元升至22.5美元;摩根士丹利:维持Vir Biotechnology"超配"评级,目标价从20美元升至24美元
02-25 11:03
Cactus (NYSE:WHD) is gearing up to announce its quarterly earnings on Wednesday...
02-25 02:02